A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

NCT02571829 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Liposarcoma
Soft Tissue Sarcoma

Interventions

DRUG: ribociclib

Sponsor

Hadassah Medical Organization